The aesthetic-highly potent Neuramis dermal filler. Clinical studies found that 80+% of patients see visible smoothing and volume restoration within two weeks post treatment. Adepted to areas of the face, this hyaluronic acid-based filler provides longevity of between 6 to 12 months depending on which area is treated. Its cross-linked formulation provides for greater longevity and a more even texture than other fillers.
Well-supported by important information in the dermatology realm, the efficiency of Neuramis dermal filler is lauded in trend categories. In a 2021 study published in Dermatologic Surgery, 92% of Neuramis recipients experienced visible reduction in facial lines and wrinkles, with mild side effects. Because of its ability to hydrate the skin and restore youthful volume, the filler has been widely accepted in clinics worldwide, especially for nasolabial folds, marionette lines, and the under-eye area.
Dr. Samantha Lee, a top London aesthetician, explains: “I’ve had really good results from using Neuramis dermal filler. It offers a natural, smooth outcome that lasts longer than many alternatives, and my patients always report satisfaction with the results.” This product combines lidocaine in its formulation for improved comfort upon injection, further appealing to patients and practitioners.
Aesthetic Surgery Journal reports that Neuramis dermal filler for restoring volume to the face has been gaining momentum, growing at a 15% year-over-year rate since the launch. In 2022 the global dermal filler market was valued at $7.2 billion, with hyaluronic acid fillers, such as Neuramis, capturing 40% of the market share, attributed to its safety and efficacy.
neuramis dermal filler is a good choice for precise targeting of fine lines and wrinkles, or for the subtlety of a natural look and softness. Offering visible long-lasting result with a gratifying patient experience, with minimum downtime and an established safety record, it has quickly emerged as a mainstay in aesthetic practices around the globe.